Federal Register / Vol. 60, No. 73 / Monday, April 17, 1995 / Notices 19267

ascites production; and current good

manufacturing practice requirements in

the production of clinical material,

including recordkeeping, processing

changes, and environmental monitoring.

Dated: April 12, 1995.

William B. Schultz,

Deputy Commissioner for Policy.

[FR Doc. 95–9411 Filed 4–14–95; 8:45 am]

BILLING CODE 4160–01–F

National Institutes of Health

National Institute of Environmental

Health Sciences; Meeting of National

Advisory Environmental Health

Sciences Council

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

National Advisory Environmental

Health Sciences Council, May 22–23,

1995, in Building 31C, Conference

Room 10, National Institutes of Health,

Bethesda, Maryland 20892.

This meeting will be open to the

public on May 22 from 9 a.m. to

approximately 3:30 p.m. for the report

of the Director, NIEHS, and for

discussion of the NIEHS budget,

program policies and issues, recent

legislation, and other items of interest.

Attendance by the public will be limited

to space available.

In accordance with the provisions set

forth in secs. 552b(c)(4) and 552b(c)(6),

Title 5, U.S.C. and sec. 10(d) of Pub. L.

92–463, the meeting will be closed to

the public on May 22 from

approximately 3:30 p.m. to recess and

from 9 a.m. to adjournment on May 23,

for the review, discussion and

evaluation of individual grant

applications.

These applications and the

discussions could reveal confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning

individuals associated with the

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Kim Whitcher, Council Secretary,

NIEHS, P.O. Box 12233, Research

Triangle Park, N.C. 27709 (919–541–

7723), will provide summaries of the

meeting and rosters of council members.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact Ms. Whitcher in advance of the

meeting.

Dr. Anne Sassaman, Director &

Executive Secretary, Division of

Extramural Research and Training,

NIEHS, P.O. Box 12233, Research

Triangle Park, North Carolina 27709,

(919) 541–7723, will furnish substantive

program information.

(Catalog of Federal Domestic Assistance

Program Nos. 93.113, Biological Response to

Environmental Agents; 93.114, Applied

Toxicological Research and Testing; 93.115,

Biometry and Risk Estimation; 93.894,

Resource and Manpower Development,

National Institutes of Health)

Dated: April 11, 1995.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–9310 Filed 4–14–95; 8:45 am]

BILLING CODE 4140–01–M

National Heart, Lung, and Blood

Institute; Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Heart,

Lung, and Blood Special Emphasis

Panel (SEP) meetings:

Name of SEP: Multidisciplinary Course on

the Genetics of Heart, Lung, and Blood

Disease (Conference Call).

Date: April 24, 1995.

Time: 12:00 p.m.

Place: Rockledge Building (RKL2), Rm.

7220, Rockville, Maryland.

Contact Person: C. James Scheirer, Ph.D.,

6701 Rockledge Drive, Room 7220, Bethesda,

Maryland 20892–7924, (301) 435–0266.

Purpose/Agenda: To review and evaluate

contract proposals.

Name of SEP: Molecular Genetics of

Hypertension—SCOR.

Date: April 30–May 1, 1995.

Time: 7:00 p.m.

Place: Holiday Inn Crowne Plaza,

Rockville, Maryland.

Contact Person: Anthony M. Coelho, Jr.,

Ph.D., 6701 Rockledge Drive, Room 7182,

Bethesda, Maryland 20892–7924, (301) 435–

0277.

Purpose/Agenda: To review and evaluate

grant applications.

Name of SEP: Programs of Excellence in

Molecular Biology.

Date: May 17, 1995.

Time: 8:30 a.m.

Place: Holiday Inn, Bethesda, Maryland.

Contact Person: Lynn M. Amende, Ph.D.,

6701 Rockledge Building, Room 7192,

Bethesda, Maryland 20892–7924, (301) 435–

0287.

Purpose/Agenda: To review and evaluate

grant applications.

These meetings will be closed in

accordance with the provisions set forth in

secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

This notice is being published less than

fifteen days prior to the meeting due to the

urgent need to meet timing limitations

imposed by the grant review cycle.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health)

Dated: April 11, 1995.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–9308 Filed 4–14–95; 8:45 am]

BILLING CODE 4140–01–M

National Heart, Lung, and Blood

Institute; Meeting of Board of Scientific

Counselors

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the Board

of Scientific Counselors, National Heart,

Lung, and Blood Institute on June 1–2,

1995, National Institutes of Health, 9000

Rockville Pike, Building 10, Room

7C101, Bethesda, Maryland 20892.

This meeting will be open to the

public from 8:30 to 9:00 a.m. on June 1

and from 8:30 to 9:00 a.m. on June 2 for

discussion of the general trends in

research relating to cardiovascular,

pulmonary and certain hematologic

diseases. Attendance by the public will

be limited to space available.

In accordance with the provisions set

forth in sec. 552b(c)(6), Title 5, U.S.C.

and sec. 10(d) of Pub. L. 92–463, the

meeting will be closed to the public

from 9:00 a.m. to adjournment on June

1 and from 9:00 a.m. to adjournment on

June 2, 1995 for the review, discussion,

and evaluation of individual programs

and projects conducted by the National

Institutes of Health, including

consideration of personnel

qualifications and performance, the

competence of individual investigators,

and similar items, the disclosure of

which would constitute a clearly

unwarranted invasion of personal

privacy.

Ms. Terry Long, Chief,

Communications and Public

Information Branch, National Heart,

Lung, and Blood Institute, Building 31,

Room 4A21, National Institutes of

Health, Bethesda, Maryland 20892,

phone (301) 496–4236, will provide a

summary of the meeting and a roster of

the Board members.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact the Executive Secretary in

advance of the meeting.

Substantive program information may

be obtained from Dr. Edward D. Korn,